前列腺癌：内分泌治疗与放射治疗相结合：前景光明。 - Suppr

Prostate cancer: Combining endocrine treatment and radiotherapy: a bright future.

作者信息

Roach Mack

机构信息

Department of Radiation Oncology, University of California San Francisco, Box 1708, San Francisco, California 94143-1708, USA.

出版信息

Nat Rev Urol. 2016 Jul;13(7):373-4. doi: 10.1038/nrurol.2016.100. Epub 2016 Jun 1.

DOI:10.1038/nrurol.2016.100

PMID:27245503

Abstract

摘要

相似文献

Prostate cancer: Combining endocrine treatment and radiotherapy: a bright future.

Nat Rev Urol. 2016 Jul;13(7):373-4. doi: 10.1038/nrurol.2016.100. Epub 2016 Jun 1.

Choice of treatment for locally advanced prostate cancer.

Prescrire Int. 2013 Jan;22(134):22.

Improving outcomes in early prostate cancer: Part I--adjuvant treatment.

BJU Int. 2006 Oct;98(4):725-30. doi: 10.1111/j.1464-410X.2006.06366.x.

[Diagnosis and treatment of prostate cancer].

Ann Urol (Paris). 1999;33(4):259-62.

Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer.

Anticancer Res. 2017 Oct;37(10):5631-5637. doi: 10.21873/anticanres.11998.

Progress in prostate cancer.

CMAJ. 1997 Dec 15;157(12):1685-6.

Advanced prostate cancer treatment guidelines: European perspective.

BJU Int. 2004 Dec;94 Suppl 3:6. doi: 10.1111/j.1464-410X.2004.05136.x.

Man With Locally Advanced, High-Risk Prostate Cancer Asks About Adding Chemotherapy to His Treatment.

Oncology (Williston Park). 2016 Jan;30(1):94-8.

New Developments in the Management of Prostate Cancer.

Oncol Res Treat. 2015;38(12):628. doi: 10.1159/000442269. Epub 2015 Nov 18.

[LHRH agonists in prostate cancer].

Prog Urol. 2007 Apr;17(2 Suppl 1):287-90.

引用本文的文献

Gut microbiota derived metabolite trimethylamine N-oxide influences prostate cancer progression via the p38/HMOX1 pathway.

Front Pharmacol. 2025 Jan 9;15:1526051. doi: 10.3389/fphar.2024.1526051. eCollection 2024.

Silencing of PSMC2 inhibits development and metastasis of prostate cancer through regulating proliferation, apoptosis and migration.

Cancer Cell Int. 2021 Apr 26;21(1):235. doi: 10.1186/s12935-021-01934-8.

本文引用的文献

Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7.

Eur Urol. 2016 Oct;70(4):684-691. doi: 10.1016/j.eururo.2016.03.021. Epub 2016 Mar 26.

Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial.

J Clin Oncol. 2016 Jun 20;34(18):2098-106. doi: 10.1200/JCO.2015.64.9285. Epub 2016 Jan 25.

Radical Prostatectomy Versus Radiation and Androgen Deprivation Therapy for Clinically Localized Prostate Cancer: How Good Is the Evidence?

Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):1064-70. doi: 10.1016/j.ijrobp.2015.08.005. Epub 2015 Nov 11.

Radical prostatectomy versus high-dose irradiation in localized/locally advanced prostate cancer: A Swedish multicenter randomized trial with patient-reported outcomes.

Acta Oncol. 2015 Jun;54(6):875-81. doi: 10.3109/0284186X.2014.974827. Epub 2014 Nov 2.

Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer.

Cochrane Database Syst Rev. 2014 Jun 30;2014(6):CD009266. doi: 10.1002/14651858.CD009266.pub2.

Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials.

Radiother Oncol. 2013 Nov;109(2):217-21. doi: 10.1016/j.radonc.2013.08.030. Epub 2013 Sep 20.

Overview of randomized controlled treatment trials for clinically localized prostate cancer: implications for active surveillance and the United States preventative task force report on screening?

J Natl Cancer Inst Monogr. 2012 Dec;2012(45):221-9. doi: 10.1093/jncimonographs/lgs039.

Causes of death after radical prostatectomy at a large tertiary center.

J Urol. 2012 Sep;188(3):798-801. doi: 10.1016/j.juro.2012.04.109. Epub 2012 Jul 20.

Prevention of gynecomastia and breast pain caused by androgen deprivation therapy in prostate cancer: tamoxifen or radiotherapy?

Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e519-24. doi: 10.1016/j.ijrobp.2012.01.036.

Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years.

BJU Int. 2010 Apr;105(8):1074-81. doi: 10.1111/j.1464-410X.2010.09319.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Prostate cancer: Combining endocrine treatment and radiotherapy: a bright future.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献